 |
|
|
| |
Associations Between Serum Biomarkers Chitinase-2-Like Protein,
Type IV Collagen, and Thrombospondin-2 With Fibrosis Stage and Clinical Outcome in Patients With Primary Sclerosing Cholangitis
|
| |
| |
EASL 2022 June 22-26 London
Michael Trauner,1 Andrew J. Muir,2 Jun Xu,3 Mina Khoshdeli,3 Vlad Malkov,1 Bryan Downie,3 Andrew N. Billin,3 Chuhan Chung,3 Robert P. Myers,3 Zachary Goodman,4
Mitchell L. Shiffman,5 Harry L.A. Janssen,5 Aldo J. Montano-Loza,6 Stephen Caldwell,7 Velimir Luketic,8 Michael Manns,9 Cynthia Levy,10 Christopher L. Bowlus11
1Medizinische Universität Wien, Austria; 2Duke Clinical Research Institute, Durham, North Carolina, USA; 3Gilead Sciences, Inc., Foster City, California, USA; 4Inova Fairfax Hospital, Falls Church, Virginia, USA; 5Bon Secours Liver Institute of Richmond, Virginia; 6University of Alberta, Edmonton, Canada; 7University of Virginia, Charlottesville; 8VCU Medical Center, Richmond; 9Medizinische Hochschule Hannover, Germany; 10University of Miami, Coral Gables, Florida, USA; 11University of California, Davis
References: 1. Harrison SA, et al. Lancet Gastroenterol Hepatol 2020;5:970-85; 2. Kozumi K, et al. Hepatology 2021;74:2452-66; 3. Okanoue T, et al. J Gastroenterol 2018;53:129-39.
Acknowledgments: We extend our thanks to the patients and their families. This study was funded by Gilead Sciences, Inc. Editing and production assistance were provided by BioScience Communications, New York, New York, USA, funded by Gilead
|
| |
|
|
|
|
|
